ARNATAR THERAPEUTICS CURE FOR CAUSE
Live / Applied — Fourth extension granted (statement of use) (as of 20 Jan 2026)
What this means for you
Not registered yet, but its 16 Sept 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97594202
- Mark type
- Design + words
- Filed
- 16 Sept 2022
- Published for opposition
- 26 Sept 2023
- Attorney of record
- Andrew T. Rissler
Goods and services
- Class 005 — Pharmaceuticals: Medicines, namely, medical preparations for preventing or treating cardiovascular and metabolic diseases, as well as rare genetic diseases
Owner
- Arnatar Therapeutics, Inc., San Diego, CA, US
- Arnatar Therapeutics, San Diego, CA, US
Prosecution history
- 20 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Jan 2026 — SOU EXTENSION 4 GRANTED
- 21 Nov 2025 — SOU EXTENSION 4 FILED
- 16 Jan 2026 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 16 Jan 2026 — NOTICE OF REVIVAL - E-MAILED
- 16 Jan 2026 — PETITION TO REVIVE-GRANTED
- 16 Jan 2026 — TEAS PETITION TO REVIVE RECEIVED
- 22 Dec 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 22 Dec 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 21 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 May 2025 — SOU EXTENSION 3 GRANTED
- 20 May 2025 — SOU EXTENSION 3 FILED
- 20 May 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Jan 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Jan 2025 — SOU EXTENSION 2 GRANTED